Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoramidic Acid SCHEMBL28135205 | 0.94 | CA2 (0.46) | CA2SLC34A1FDPSKDM4EBLM | |
| Phosphoramidic Acid SCHEMBL25846 | 0.94 | — | — | |
| Phosphoramidic Acid SCHEMBL30498012 | 0.94 | CA2 (0.46) | CA2SLC34A1FDPSKDM4EBLM | |
| Phosphoramidic Acid SCHEMBL15067183 | 0.89 | CA2 (0.42) | CA2SLC34A1FDPSKDM4EBLM | |
| Phosphoramidic Acid SCHEMBL7136498 | 0.89 | — | — | |
| Phosphoramidic Acid SCHEMBL17076496 | 0.89 | — | — | |
| Phosphoramidic Acid SCHEMBL3805753 | 0.89 | — | — | |
| Phosphoramidic Acid SCHEMBL21646133 | 0.89 | — | — | |
| Phosphoramidic Acid SCHEMBL4844119 | 0.89 | — | — | |
| Phosphoramidic Acid SCHEMBL15067660 | 0.89 | CA2 (0.42) | CA2SLC34A1FDPSKDM4EBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119841869-A | Preparation method of phosphorus-nitrogen synergistic flame retardant | 浙江新化化工股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-7678542-B2 | Charge tags and the separation of nucleic acid molecules | THIRD WAVE TECHNOLOGIES, INC. (US) | 2010-03-16 | — | — | US | disclosed |
| US-20090078574-A1 | CHARGE TAGS AND THE SEPARATION OF NUCLEIC ACID MOLECULES | THIRD WAVE TECHNOLOGIES, INC. (US) | 2009-03-26 | — | — | US | disclosed |
| CN-101351120-A | Solid crop protection agents containing polyalkoxylate, method for their production and use thereof | BASF SE (DE) | 2009-01-21 | — | — | CN | disclosed |
| EP-1385996-B1 | Charge tag and separation of nucleic acid molecules | THIRD WAVE TECH INC (US) | 2008-08-06 | — | — | EP | disclosed |
| US-7384746-B2 | Charge tags and the separation of nucleic acid molecules | THIRD WAVE TECHNOLOGIES, INC. (US) | 2008-06-10 | — | — | US | disclosed |
| US-20050130179-A1 | Charge tags and the separation of nucleic acid molecules | THIRD WAVE TECHNOLOGIES, INC. (US) | 2005-06-16 | — | — | US | disclosed |
| US-6780982-B2 | COMPOSITION FOR USE AS DETECTION AND SEPARATION TOOLS IN NUCLEOTIDE SEQUENCES ANALYSIS | THIRD WAVE TECHNOLOGIES, INC. | 2004-08-24 | — | — | US | disclosed |
| US-6699979-B2 | PREPARED VIA A STEREOSPECIFIC SN2 NUCLEOPHILIC ATTACK OF A PHOSPHODIESTER, OR PHOSPHOROTHIOATE, ON THE 3' POSITION OF A XYLONUCLEOTIDE; USEFUL IN ANTISENSE OR PROBE TECHNOLOGY | ISIS PHARMACEUTICALS, INC. | 2004-03-02 | — | — | US | disclosed |
| EP-1385996-A2 | CHARGE TAGS AND SEPARATION OF NUCLEIC ACID MOLECULES | THIRD WAVE TECHNOLOGIES, INC. (US) | 2004-02-04 | — | — | EP | disclosed |
| US-20020128465-A1 | Charge tags and the separation of nucleic acid molecules | THIRD WAVE TECHNOLOGIES, INC. | 2002-09-12 | — | — | US | disclosed |
| WO-2002063030-A2 | CHARGE TAGS AND SEPARATION OF NUCLEIC ACID MOLECULES | THIRD WAVE TECHNOLOGIES, INC. (US) | 2002-08-15 | — | — | WO | disclosed |
| EP-0655088-B1 | OLIGONUCLEOTIDES HAVING CHIRAL PHOSPHORUS LINKAGES | ISIS PHARMACEUTICALS INC (US) | 2002-07-24 | — | — | EP | disclosed |
| US-20010008936-A1 | Oligonucleotides having chiral phosphorus linkages | ISIS PHARMACEUTICALS, INC. | 2001-07-19 | — | — | US | disclosed |
| US-6239265-B1 | FOR RESEARCH AND DIAGNOSIS | ISIS PHARMACEUTICALS, INC. | 2001-05-29 | — | — | US | disclosed |
| US-5852188-A | Oligonucleotides having chiral phosphorus linkages | ISIS PHARMACEUTICALS, INC. (US) | 1998-12-22 | — | — | US | disclosed |
| US-5521302-A | NUCLEOPHILIC REACTION OF PHOSPHATE GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0655088-A1 | OLIGONUCLEOTIDES HAVING CHIRAL PHOSPHORUS LINKAGES | ISIS PHARMACEUTICALS, INC. (US) | 1995-05-31 | — | — | EP | disclosed |
| US-5212295-A | Monomers for preparation of oligonucleotides having chiral phosphorus linkages | ISIS PHARMACEUTICALS (US) | 1993-05-18 | — | — | US | disclosed |
| WO-1993008296-A1 | OLIGONUCLEOTIDES HAVING CHIRAL PHOSPHORUS LINKAGES | ISIS PHARMACEUTICALS, INC. (US) | 1993-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050130179-A1 | Charge tags and the separation of nucleic acid molecules | NSUN2, NSUN3, NCL | CA2 1407/4885SLC34A1 389/4885FDPS 4070/4885 |
| US-20020128465-A1 | Charge tags and the separation of nucleic acid molecules | NSUN2, NSUN3, NCL | CA2 1407/4885SLC34A1 389/4885FDPS 4070/4885 |
| US-20010008936-A1 | Oligonucleotides having chiral phosphorus linkages | RNGTT, PNP, PSPH | CA2 3545/4885SLC34A1 129/4885FDPS 428/4885 |
| US-20090078574-A1 | CHARGE TAGS AND THE SEPARATION OF NUCLEIC ACID MOLECULES | NSUN2, NSUN3, NCL | CA2 1407/4885SLC34A1 389/4885FDPS 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.